Search

everythinglearnresearchcommunity

for

Search:↓

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

PGD2 stops hair growth and is higher in bald men with AGA.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Some women with common hair loss may develop permanent hair loss.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.